Crossmark

<scp>ADAM</scp> 17 selectively activates the <scp>IL</scp> ‐6 trans‐signaling/ <scp>ERK MAPK</scp> axis in <scp>KRAS</scp> ‐addicted lung cancer

Crossref DOI link: https://doi.org/10.15252/emmm.201809976

Published Online: 2019-03-04

Published Print: 2019-04

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Saad, Mohamed I https://orcid.org/0000-0002-4855-2360
Alhayyani, Sultan

McLeod, Louise

Yu, Liang

Alanazi, Mohammad

Deswaerte, Virginie

Tang, Ke

Jarde, Thierry

Smith, Julian A

Prodanovic, Zdenka

Tate, Michelle D

Balic, Jesse J

Watkins, D Neil

Cain, Jason E

Bozinovski, Steven

Algar, Elizabeth

Kohmoto, Tomohiro

Ebi, Hiromichi

Ferlin, Walter

Garbers, Christoph

Ruwanpura, Saleela

Sagi, Irit

Rose‐John, Stefan

Jenkins, Brendan J https://orcid.org/0000-0002-7552-4656
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (CRC841, CRC877, SFB877, A10, A14)

National Health and Medical Research Council (1063998)
License Information

Version of Record valid from 2019-03-04
More Information

Publication History

Received: 2018-10-23

Accepted: 2019-02-06

Published: 2019-03-04